Analyst firms · Argus Research · CNC
Argus Research CNC price target and rating history
Centene Corporation (CNC) · Health Care
Argus Research rates Centene Corporation (CNC) Buy with a $80 price target, as of its latest action on Aug 11, 2026. It has published 3 rating actions on CNC since September 2022, including 1 upgrade and 1 downgrade. Across 6 firms with a CNC price target in the last 12 months, the median target is $65. Argus Research's $80 is 23% above that.
- Current rating
- Buy
- Price target
- $80
- Median target, all firms
- $65
- Actions on CNC
- 3
Argus Research price target on CNC
Every Argus Research rating on CNC
- Aug 11, 2026
- Feb 6, 2025
- Sep 30, 2022
How other firms rate CNC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Argus Research | Buy | $80 | Aug 11, 2026 |
| RBC Capital Markets | Sector Perform | $70 | Jun 23, 2026 |
| Deutsche Bank | Buy | $80 | May 20, 2026 |
| Cantor Fitzgerald | Overweight | $60 | Apr 29, 2026 |
| BofA Securities | Buy | $60 | Apr 29, 2026 |
| Barclays | Overweight | $54 | Jan 5, 2026 |
Questions about Argus Research and CNC
- What is Argus Research's price target for CNC?
- Argus Research's latest stated price target for Centene Corporation (CNC) is $80, from its action on Aug 11, 2026.
- What is Argus Research's rating on CNC?
- Argus Research rates CNC Buy, a bullish rating, as of Aug 11, 2026.
- When did Argus Research last change its view on CNC?
- On Aug 11, 2026, Argus Research upgrades to Buy from Hold, price target $80.
- How does Argus Research's CNC target compare with other analysts?
- Across 6 firms with a CNC price target in the last 12 months, the median target is $65. Argus Research's $80 is 23% above that.
More CNC rating histories
- Deutsche Bank3
- Cantor Fitzgerald3
- BofA Securities5
- Barclays5
- Wells Fargo5
- Morgan Stanley7
- UBS3
- Jefferies4
- Credit Suisse4
All Argus Research ratingsCNC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.